Novartis Takes On Servier’s Antidepressant

Novartis is poised to enter the depression market through a licensing agreement with Servier

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet